efalizumab   Click here for help

GtoPdb Ligand ID: 6593

Synonyms: anti alphaL integrin | antiCD11 alpha | hu1124 | Raptiva®
Approved drug Immunopharmacology Ligand
efalizumab is an approved drug (FDA (2003), EMA (2004))
Compound class: Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
References
1. Jardieu PM, Presta LG. (2004)
Method of treatment using humanized anti-CD11a antibodies.
Patent number: US6703018. Assignee: Genentech, Inc.. Priority date: 27/11/1996. Publication date: 19/03/2004.